Location History:
- Taipei, TW (2020 - 2021)
- Irvine, CA (US) (2023)
Company Filing History:
Years Active: 2020-2023
Title: Madhu Cherukury: Innovator in Biotherapeutics
Introduction
Madhu Cherukury is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotherapeutics, particularly in the area of angiogenesis inhibition. With a total of 3 patents to his name, Cherukury is recognized for his innovative approaches to medical treatments.
Latest Patents
Cherukury's latest patents include a VEGFR fusion protein pharmaceutical composition. This invention relates to a biologic that inhibits angiogenesis, specifically through fusion proteins that target both the integrin activated pathway and another angiogenic factor-activated pathway. Additionally, he has developed fusion proteins for inhibiting angiogenesis, which also focus on the same pathways and include methods for producing and utilizing these compositions.
Career Highlights
Madhu Cherukury is currently associated with Allgenesis Biotherapeutics Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for conditions related to abnormal blood vessel growth.
Collaborations
Cherukury collaborates with talented individuals in his field, including Pei-Tzu Wu and Tan Nguyen. These partnerships enhance the innovative potential of his projects and contribute to the success of their shared goals.
Conclusion
Madhu Cherukury stands out as an influential inventor in the biotherapeutics sector, with a focus on angiogenesis inhibition. His contributions through patents and collaborations are paving the way for advancements in medical treatments.